申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US04783471A1
公开(公告)日:1988-11-08
This invention relates to a new class of compounds having important biochemical and pharmacological properties. More particularly, this invention relates to N-aralkyl piperidinemethanol derivatives which are potent and selective inhibitors of the binding of serotonin at the 5HT.sub.2 receptor site, and to the processes for their preparation and use.
这项发明涉及一类具有重要生化和药理特性的新化合物。更具体地说,这项发明涉及N-芳基哌啶甲醇衍生物,这些衍生物是5HT.sub.2受体位点上血清素结合的有效和选择性抑制剂,并涉及其制备和使用的方法。